| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9M | — | — |
| SG&A Expense | $7.5M | — | +275.2% |
| Operating Income | -$4.6M | — | -95.2% |
| Pre-tax Income | -$77.5M | — | -3172.5% |
| Net Income | -$76.3M | — | -3118.9% |
| EPS (Basic) | -$3.64 | — | -443.3% |
| EPS (Diluted) | -$3.64 | — | -443.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $65.9M | +722.0% | — |
| Short-term Investments | $31.8M | +620.3% | — |
| Accounts Receivable | $375K | — | — |
| Current Assets | $82.5M | +508.1% | +1948.4% |
| Total Assets | $207.6M | -32.2% | +1681.9% |
| Current Liabilities | $13.3M | -67.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.4M | — | -2295.4% |
| Capital Expenditures | $16.8M | — | — |
| Investing Cash Flow | $71.8M | — | — |
| Financing Cash Flow | $5.5M | — | — |
| Free Cash Flow | -$37.3M | — | — |
| +238.0% |
| Total Liabilities | $39.3M | -41.3% | +895.5% |
| Stockholders' Equity | $168.3M | -29.7% | +2084.6% |